Page last updated: 2024-08-22

dithiothreitol and ER-Negative PR-Negative HER2-Negative Breast Cancer

dithiothreitol has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cai, K; Chen, Q; Chen, X; Cheng, J; Guo, Q; He, X; Jiang, C; Li, C; Liu, L; Lu, Y; Ruan, C; Sun, T; Zhang, Y	1

Other Studies

1 other study(ies) available for dithiothreitol and ER-Negative PR-Negative HER2-Negative Breast Cancer

Article	Year
Dimeric Prodrug Self-Delivery Nanoparticles with Enhanced Drug Loading and Bioreduction Responsiveness for Targeted Cancer Therapy. ACS applied materials & interfaces, 2018, Nov-21, Volume: 10, Issue:46 Topics: Animals; Antineoplastic Agents; Apoptosis; Camptothecin; Cell Line, Tumor; Dimerization; Dithiothreitol; Drug Carriers; Endocytosis; Female; Fluorescence Resonance Energy Transfer; HEK293 Cells; Humans; Ligands; Mice; Micelles; Nanoparticles; Neoplasms; Neurotensin; Oxidation-Reduction; Polymers; Prodrugs; Temperature; Triple Negative Breast Neoplasms	2018

Article

Year

Dimeric Prodrug Self-Delivery Nanoparticles with Enhanced Drug Loading and Bioreduction Responsiveness for Targeted Cancer Therapy.

ACS applied materials & interfaces, 2018, Nov-21, Volume: 10, Issue:46

Topics: Animals; Antineoplastic Agents; Apoptosis; Camptothecin; Cell Line, Tumor; Dimerization; Dithiothreitol; Drug Carriers; Endocytosis; Female; Fluorescence Resonance Energy Transfer; HEK293 Cells; Humans; Ligands; Mice; Micelles; Nanoparticles; Neoplasms; Neurotensin; Oxidation-Reduction; Polymers; Prodrugs; Temperature; Triple Negative Breast Neoplasms

2018